Table 2 The list of miRNAs related clinical trials documented up to May 2019
From: Tumor-derived extracellular vesicles: reliable tools for Cancer diagnosis and clinical applications
Condition or disease | Type of miRNA | Phase | NCT number |
|---|---|---|---|
Breast Cancer | Total | Phase-II | NCT02127073 |
Total | Phase-IV | NCT01612871 | |
Total | ND | NCT03779022 | |
Total | ND | NCT01598285 | |
Total | ND | NCT02656589 | |
Total | ND | NCT02065908 | |
Total | ND | NCT01231386 | |
Total | ND | NCT01722851 | |
Total | ND | NCT01957332 | |
Total | ND | NCT02950207 | |
Prostate Cancer | Total | ND | NCT01220427 |
Total | ND | NCT02366494 | |
Total | ND | NCT02964351 | |
Pancreatic Cancer | Total | Phase-II | NCT02634502 |
Total | ND | NCT02531607 | |
miR-25 | ND | NCT03432624 | |
Colorectal Cancer | miR-31-3p and miR-31-5p | Phase-III | NCT03362684 |
total | ND | NCT03309722 | |
Total | ND | NCT02876133 | |
Total | ND | NCT01712958 | |
Bladder Cancer | miR-155 | ND | NCT03591367 |
Esophageal Cancer | Total | Phase-II | NCT02392377 |
Total | ND | NCT02812680 | |
Lung Cancer | Total | ND | NCT02247453 |
Total | ND | NCT03452514 | |
Total | ND | NCT03397355 | |
Total | ND | NCT03293433 | |
Thyroid Cancer | Total | ND | NCT01964508 |
Total | ND | NCT01433809 | |
Brain Tumors | Total | ND | NCT03630861 |
Total | ND | NCT01595126 | |
Oral Cancer | miR-21 and miR-200 | Phase-III | NCT03685409 |
Total | Phase-IV | NCT03684707 | |
microRNA-29b | ND | NCT02009852 | |
Skin Cancer | Total | ND | NCT00849914 |
Total | ND | NCT01143311 | |
Total | ND | NCT01345760 | |
Kidney Cancer | Total | ND | NCT00806650 |
Endometrial Cancer | Total | ND | NCT01119573 |
Ovarian Cancer | Total | ND | NCT02758652 |
Total | ND | NCT03738319 | |
Cancer of Head and Neck | microRNA-29 family | ND | NCT01927354 |
Leukemia | Total | ND | NCT01505699 |
microRNA-34a and | ND | NCT01057199 | |
microRNA-194 | Â | Â | |
Total | ND | NCT01229124 | |
Total | ND | NCT01511575 | |
Total | ND | NCT00896766 | |
Liver | Total | ND | NCT02448056 |
Total | ND | NCT03227510 | |
miR-221 and miR-222 | ND | NCT02928627 | |
Total | ND | NCT01247506 |